학술논문
Biomarker analysis of phase II pembrolizumab maintenance treatment after chemotherapy response in patients with HER2-negative inflammatory breast cancer and triple-negative breast cancer.
Document Type
Article
Author
Iwase, Toshiaki; Alexander, Angela; Cohen, Evan N.; Gao, Hui; Chiv, Vivian Y; Kai, Megumi; Kida, Kumiko; Krishnamurthy, Savitri; Liu, Dianne; Shen, Yu; Ramirez, David Luis; Reuben, Alexandre; Tripathy, Debu; Booser, Daniel J.; Moulder, Stacy L.; Yam, Clinton; Valero, Vicente; Lim, Bora; Reuben, James M.; Ueno, Naoto T.
Source
Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p1105-1105, 1p
Subject
Language
ISSN
0732183X